innoscripta Aktie
| 108,80EUR | 1,40EUR | 1,30% |
WKN DE: A40QVM / ISIN: DE000A40QVM8
Personal
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 0 | 0 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Summe Umlaufvermögen | 17 | 29 | 35 | 58 |
| Summe Anlagevermögen | 0 | 1 | 1 | 1 |
| Summe Aktiva | 17 | 30 | 35 | 59 |
Bilanz (in Mio. EUR) - Passiva
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Summe Fremdkapital | 7 | 17 | 17 | 24 |
| Summe Eigenkapital | 11 | 13 | 18 | 35 |
| Summe Passiva | 17 | 30 | 35 | 59 |
Adresse
| Arnulfstrasse 60, 80335 Munich | |
| Telefon | +49 (89) 25555-3537 |
| Internet | http://www.innoscripta.com |
Management
|
Alexander Meyer
Chief Financial Officer |
|
Christoph Möller
Deputy Chairman-Supervisory Board |
|
Duygu Uysal
Member-Supervisory Board |
|
Erik Massmann
Member-Supervisory Board |
|
Kai Andrejewski
Member-Supervisory Board |
|
Michael Georg Hohenester
Chief Executive Officer |
|
Philipp von Ilberg
Chairman-Supervisory Board |
|
Sebastian Schwertlein
Chief Operating Officer |
|
Stefan Berndt-von Bülow
Member-Supervisory Board |